Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 46 Records) |
| Query Trace: Carcinoma and FGFR1[original query] |
|---|
| FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib. Cancer science 2016 Sep . Hibi Masaaki, Kaneda Hiroyasu, Tanizaki Junko, Sakai Kazuko, Togashi Yosuke, Terashima Masato, De Velasco Marco Antonio, Fujita Yoshihiko, Banno Eri, Nakamura Yu, Takeda Masayuki, Ito Akihiko, Mitsudomi Tetsuya, Nakagawa Kazuhiko, Okamoto Isamu, Nishio Kazu |
| Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Aug . Miyoshi Tomohiro, Umemura Shigeki, Matsumura Yuki, Mimaki Sachiyo, Tada Satoshi, Ishii Genichiro, Udagawa Hibiki, Matsumoto Shingo, Yoh Kiyotaka, Niho Seiji, Ohmatsu Hironobu, Aokage Keiju, Hishida Tomoyuki, Yoshida Junji, Nagai Kanji, Goto Koichi, Tsuboi Masahiro, Tsuchihara Katsu |
| Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations. Cancer 2016 Jul . Chiosea Simion I, Thompson Lester D R, Weinreb Ilan, Bauman Julie E, Mahaffey Alyssa M, Miller Caitlyn, Ferris Robert L, Gooding William |
| Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma. European journal of cancer (Oxford, England : 1990) 2016 Feb 57 91-103. Yang Ching-Yao, Lin Mong-Wei, Chang Yih-Leong, Wu Chen-Tu, Yang Pan-Ch |
| FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer. Virchows Archiv : an international journal of pathology 2017 Dec . Flockerzi Fidelis Andrea, Roggia Cristiana, Langer Frank, Holleczek Bernd, Bohle Rainer |
| Association of fibroblast growth factor receptor 1 gene amplification with poor survival in patients with esophageal squamous cell carcinoma. Oncotarget 2017 Oct 8 (51): 88857-88869. Wang Dong, Du Licheng, Wang Zhou, Liu Xiangyan, Qin Yejun, Wang Qiangxiu, Yang Zhe, Yao Zhigang, Shi Mo, Shang Bin, Jia Yang, Chen Huaxia, Qiao Liang, Wang Xueqing, Xiao Zhaohua, Liu Zhenchu |
| Association Between Fibroblast Growth Factor Receptor 1 Gene Amplification and Human Papillomavirus Prevalence in Tonsillar Squamous Cell Carcinoma With Clinicopathologic Analysis. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2018 3 66 (7): 511-522. Park Soonchan, Lee Miji, Cho Kyung-Ja, Kim Sung Bae, Roh Jong-Lyel, Choi Seung-Ho, Nam Soon Yuhl, Kim Sang Yoon, Song Joon Se |
| Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival. European journal of cancer (Oxford, England : 1990) 2018 Jan 91 47-55. Dubot C, Bernard V, Sablin M P, Vacher S, Chemlali W, Schnitzler A, Pierron G, Ait Rais K, Bessoltane N, Jeannot E, Klijanienko J, Mariani O, Jouffroy T, Calugaru V, Hoffmann C, Lesnik M, Badois N, Berger F, Le Tourneau C, Kamal M, Bieche |
| Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancer. Scientific reports 2019 2 9 (1): 1482. Kaur Pushpinder, Porras Tania B, Ring Alexander, Carpten John D, Lang Julie |
| Moderate-to-strong expression of FGFR3 and TP53 alterations in a subpopulation of choroid plexus tumors. Histology and histopathology 2019 10 35 (7): 673-680. Granberg Kirsi J, Raita Annina, Lehtinen Birgitta, Tiihonen Aliisa M, Kesseli Juha, Annala Matti, Rodriguez-Martinez Alejandra, Nordfors Kristiina, Zhang Wei, Visakorpi Tapio, Nykter Matti, Haapasalo Han |
| Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma. PeerJ 2020 8 e9294. Dutta Munmee, Nakagawa Hidewaki, Kato Hiroaki, Maejima Kazuhiro, Sasagawa Shota, Nakano Kaoru, Sasaki-Oku Aya, Fujimoto Akihiro, Mateos Raúl Nicolás, Patil Ashwini, Tanaka Hiroko, Miyano Satoru, Yasuda Takushi, Nakai Kenta, Fujita Masas |
| Comprehensive Genomic Profiling of Rare Tumors: Routes to Targeted Therapies. Frontiers in oncology 2020 5 10 536. Wang Shuhang, Chen Rongrong, Tang Yu, Yu Yue, Fang Yuan, Huang Huiyao, Wu Dawei, Fang Hong, Bai Ying, Sun Chao, Yu Anqi, Fan Qi, Gu Dejian, Yi Xin, Li Ni |
| Comprehensive Molecular Characterizations of Chinese Patients With Different Subtypes of Lung Squamous Cell Carcinoma. Frontiers in oncology 2020 10 607130. Qian Jie, Chen Rongrong, Zhao Ruiying, Han Yuchen, Yu Yongfe |
| Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
| TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 11 34 (6): 1133-1142. Brown Noah A, Plouffe Komal R, Yilmaz Osman, Weindorf Steven C, Betz Bryan L, Carey Thomas E, Seethala Raja R, McHugh Jonathan B, Tomlins Scott A, Udager Aaron |
| Identifying Genomic Alterations in Patients With Stage IV Breast Cancer Using MammaSeq: An International Collaborative Study. Clinical breast cancer 2020 11 21 (3): 210-217. Shah Osama Shiraz, Soran Atilla, Sahin Mustafa, Knapick Beth A, Ugras Serdar, Celik Esin, Lucas Peter C, Lee Adrian |
| Prognostic Genetic Biomarkers Based on Oncogenic Signaling Pathways for Outcome Prediction in Patients with Oral Cavity Squamous Cell Carcinoma. Cancers 2021 May 13 (11): . Fan Wen-Lang, Yang Lan-Yan, Hsieh Jason Chia-Hsun, Lin Tsung-Chieh, Lu Mei-Yeh Jade, Liao Chun- |
| Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations. Oncotarget 2021 4 12 (6): 578-588. Joshi Asim, Mishra Rohit, Desai Sanket, Chandrani Pratik, Kore Hitesh, Sunder Roma, Hait Supriya, Iyer Prajish, Trivedi Vaishakhi, Choughule Anuradha, Noronha Vanita, Joshi Amit, Patil Vijay, Menon Nandini, Kumar Rajiv, Prabhash Kumar, Dutt Am |
| Predictive values of genomic variation, tumor mutational burden, and PD-L1 expression in advanced lung squamous cell carcinoma treated with immunotherapy. Translational lung cancer research 2020 Dec 9 (6): 2367-2379. Xu Yanjun, Li Hui, Huang Zhiyu, Chen Kaiyan, Yu Xiaoqing, Sheng Jiamin, Zhang Han-Han, Fan Y |
| Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Toxicity and Efficacy in Non-Small-Cell Lung Cancer. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): e437. He K, Zhang S, Pang J, Yin J, Zhang J, Mu D, Tang S, Li L, Bao H, Wu X, Wang X, Shao Y, Yu J, Yuan |
| Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer. Cancer journal (Sudbury, Mass.) 2022 9 28 (5): 354-362. Wang Zechen, Anderson Karen |
| Comprehensive Analysis of Genomic Alterations in Hepatoid Adenocarcinoma of the Stomach and Identification of Clinically Actionable Alterations. Cancers 2022 08 14 (16): . Zhao Rongjie, Li Hongshen, Ge Weiting, Zhu Xiuming, Zhu Liang, Wan Xiangbo, Wang Guanglan, Pan Hongming, Lu Jie, Han Weido |
| PD-L1 expression and FGFR-mutations among Danish patients diagnosed with metastatic urothelial carcinoma: A retrospective and descriptive study. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2022 5 130 (8): 498-506. Grantzau Trine, Toft Birgitte Grønkaer, Melchior Linea Cecilie, Elversang Johanna, Stormoen Dag Rune, Omland Lise Høj, Pappot Hel |
| Non-Lobular Invasive Breast Carcinomas with Bi-Allelic Pathogenic CDH1 Somatic Alterations: a Histologic, Immunophenotypic and Genomic Characterization. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 11 100375. Fatemeh Derakhshan, Arnaud Da Cruz Paula, Pier Selenica, Edaise M da Silva, Anne Grabenstetter, Sahar Jalali, Andrea M Gazzo, Higinio Dopeso, Antonio Marra, David N Brown, Dara S Ross, Diana Mandelker, Pedram Razavi, Sarat Chandarlapaty, Hannah Y Wen, Edi Brogi, Hong Zhang, Britta Weigelt, Fresia Pareja, Jorge S Reis-Fil |
| Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases. Annals of diagnostic pathology 2023 1 63 152082. Demleitner Madeleine, Erlenbach-Wünsch Katharina, Coras Roland, Erber Ramona, Polifka Iris, Eyüpo?lu Ilker, Fuchs Florian, Hartmann Arndt, Agaimy Abb |
| Somatic KMT2D loss-of-function mutations in lung squamous cell carcinoma: a single-center cohort study. Journal of thoracic disease 2024 6 16 (5): 3338-3349. Zekui Fang, Xiping Wu, Li Xiao, Chunli Wang, Yanyan Zhao, Qingchao Zhang, Paola Anna Jablonska, Alonso La Rosa, Wolfram C M Dempke, Muhammad Furqan, Huizhen F |
| Comprehensive genomic profiling from C-CAT database unveiled over 80% presence of oncogenic drivers in anaplastic thyroid carcinoma including BRAF, RAS family, NF1, and FGFR1. Clinical endocrinology 2024 6 . Yuki Saito, Hidenori Kage, Kenya Kobayashi, Teru Kamogashira, Osamu Fukuoka, Koji Yamamura, Satoshi Yamashita, Masahiko Tanabe, Katsutoshi Oda, Kenji Kon |
| Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1. JCO precision oncology 2024 4 8 e2300406. Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane, Larry V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Ajjai S Alva, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaher |
| Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2. JCO precision oncology 2024 4 8 e2300407. Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane, Larry V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaher |
| FGFR2 point mutation in 2 cases of pleomorphic adenoma progressing to myoepithelial carcinoma. Contemporary oncology (Poznan, Poland) 2024 1 27 (3): 211-216. Julia Pikul, Anna Rzepakowska, Marcin Machnicki, Tomasz Stok?o |
- Page last reviewed:Feb 1, 2024
- Content source: